BIOA — BioAge Labs, Inc. catalysts
Next verified catalyst
2026-11-30 — A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Pa · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-30 in 4mo
ESTIMATED |
READOUT
A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE
Phase 2 · Obesity and Cardiovascular Risk |
BIOA BioAge Labs, Inc. | Oral BGE-102, Oral Placebo Matching BGE- |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|